Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-06-28
2011-06-28
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S293000, C546S244000
Reexamination Certificate
active
07968568
ABSTRACT:
This invention is concerned with compounds of the formulawherein A, R1to R5and G are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are associated with the modulation of SST receptors subtype 5.
REFERENCES:
patent: 2006/0052599 (2006-03-01), Ishibashi et al.
patent: 2007/0167459 (2007-07-01), Habashita et al.
patent: WO 01/44191 (2001-06-01), None
Christ Andreas D.
Martin Rainer E.
Hoffmann-La Roche Inc.
Johnston George W.
Megerditchian Samuel H.
Tramaloni Dennis P.
Willis Douglas M
LandOfFree
Substituted piperidine derivatives as SST5 modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted piperidine derivatives as SST5 modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted piperidine derivatives as SST5 modulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2731394